Major response to imatinib mesylate in KIT-mutated melanoma.
作者信息
Hodi F Stephen, Friedlander Philip, Corless Christopher L, Heinrich Michael C, Mac Rae Suzanne, Kruse Andrea, Jagannathan Jyothi, Van den Abbeele Annick D, Velazquez Elsa F, Demetri George D, Fisher David E
机构信息
The Melanoma Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
出版信息
J Clin Oncol. 2008 Apr 20;26(12):2046-51. doi: 10.1200/JCO.2007.14.0707.
PMID:18421059
Abstract
摘要
Zotero 插件